https://www.mdpi.com/1422-0067/22/20/10984/htm
G-Quadruplex Targeting in the Fight against Viruses: An Update
Department of Molecular Medicine, University of Padua, 35121 Padua, Italy
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Academic Editor: Alessandro Di Minno
Int. J. Mol. Sci. 2021, 22(20), 10984; https://doi.org/10.3390/ijms222010984
Received: 20 September 2021
/
Revised: 7 October 2021
/
Accepted: 8 October 2021
/
Published: 12 October 2021
Abstract
G-quadruplexes (G4s) are noncanonical nucleic acid structures involved
in the regulation of key cellular processes, such as transcription and
replication. Since their discovery, G4s have been mainly investigated
for their role in cancer and as targets in anticancer therapy. More
recently, exploration of the presence and role of G4s in viral genomes
has led to the discovery of G4-regulated key viral pathways. In this
context, employment of selective G4 ligands has helped to understand the
complexity of G4-mediated mechanisms in the viral life cycle, and
highlighted the possibility to target viral G4s as an emerging antiviral
approach. Research in this field is growing at a fast pace, providing
increasing evidence of the antiviral activity of old and new G4 ligands.
This review aims to provide a punctual update on the literature on G4
ligands exploited in virology. Different classes of G4 binders are
described, with emphasis on possible antiviral applications in emerging
diseases, such as the current COVID-19 pandemic. Strengths and
weaknesses of G4 targeting in viruses are discussed.
View Full-Text
Keywords:
G-quadruplexes; virus; targeting; G-quadruplex ligands; antiviral therapy
▼
Show Figures
Inga kommentarer:
Skicka en kommentar